As the domestic owners of major drugs such as Valcyte, Alvesco, and Bonviva changed, they were newly reflected in the salary list. All three items were previously copyrighted by the Korean branch of a global pharmaceutical company, but now domestic pharmaceutical companies are the owners. In the case of Valcyte 440mg, pharmaceutical companies will be changed from February 1st from Roche Korea to Chong Kun Dang. The transfer of permission rights has already been completed. The drug is used to treat CMV retinitis in adult AIDS patients. Roche has been copyrighted and sold in Korea in cooperation with Chong Kun Dang, but Chong Kun Dang will sell exclusively in the future. The global copyright of the drug has already been